Adenocarcinoma  >>  Merck (MSD)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials
 02468101214161820
            
            
             
Zolinza (vorinostat) / Merck (MSD)           
          
            
             
MK-2206 / Merck (MSD)           
          
            
             
Koselugo (selumetinib) / Merck (MSD), AstraZeneca           
          
            
             
dalotuzumab (MK 0646) / Merck (MSD), Pierre Fabre           
          
            
             
dalantercept (ACE-041) / Merck (MSD)